<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HDA38F3EE58BA43C1A3DAF683C65CC651" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 4007 IH: Halting the Epidemic of Addiction and Loss Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-06-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4007</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230612">June 12, 2023</action-date><action-desc><sponsor name-id="A000377">Mr. Armstrong</sponsor> (for himself and <cosponsor name-id="T000469">Mr. Tonko</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To ensure references to opioid overdose reversal agents in grant programs of the Department of Health and Human Services are not limited to naloxone.</official-title></form><legis-body id="HCA52F94937B74DB799226F44D4AE349D" style="OLC"> 
<section id="HF8B243953D0745558F4BD5A87E122429" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Halting the Epidemic of Addiction and Loss Act of 2023</short-title></quote> or the <quote><short-title>HEAL Act of 2023</short-title></quote>.</text></section> <section id="H29FFFBABAE11487B81BE4C3238981414"><enum>2.</enum><header>References to opioid overdose reversal agents in HHS grant programs</header> <subsection id="H891930FD958147B8A5E04396DDE39AB5"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall ensure that, whenever the Department of Health and Human Services issues a regulation, guidance, or other document for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal agent (such as a reference to naloxone) is inclusive of any opioid overdose reversal agent that has been approved or otherwise authorized for use by the Food and Drug Administration.</text></subsection> 
<subsection id="H817A612C6BC14D5390972610B6EC2D02" commented="no"><enum>(b)</enum><header>Existing references</header><text display-inline="yes-display-inline"></text> <paragraph id="HB799354E49014830A33EBE195C792D7D" commented="no"><enum>(1)</enum><header>Update</header><text>Not later than the end of calendar year 2023, the Secretary of Health and Human Services shall update all references described in paragraph (2) to be inclusive of any opioid overdose reversal agent that has been approved or otherwise authorized for use by the Food and Drug Administration.</text></paragraph> 
<paragraph id="HEA7B7E6D2AE94C9BBE51DAD4086CB846" commented="no"><enum>(2)</enum><header>References</header><text>A reference described in this paragraph is any reference to an opioid overdose reversal agent (such as naloxone) in any regulation, guidance, or other document of the Department of Health and Human Services that—</text> <subparagraph id="HBFFA9B683A4143C8995A7FADC85B5D5F" commented="no"><enum>(A)</enum><text>was issued before the date of enactment of this Act; and</text></subparagraph> 
<subparagraph id="HCA18965EFF30452AA3CB4A6A1FC355CF" commented="no"><enum>(B)</enum><text>is for—</text> <clause id="HEF17EA9579AC4B36973EAE1734E23A7F" commented="no"><enum>(i)</enum><text display-inline="yes-display-inline">the grant program for State and Tribal response to opioid use disorders under section 1003 of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note; commonly referred to as <quote>State Opioid Response Grants</quote> and <quote>Tribal Opioid Response Grants</quote>); or</text></clause> 
<clause id="H41D2C5BE725A4788B7AF78E11384A9C3" commented="no"><enum>(ii)</enum><text>the grant program for priority substance use disorder prevention needs of regional and national significance under section 516 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-22">42 U.S.C. 290bb–22</external-xref>).</text></clause> </subparagraph></paragraph> </subsection></section> </legis-body></bill> 

